The ENGAGE study: evaluation of a conversational virtual agent that provides tailored pre-test genetic education to cancer patients.

Journal: Journal of cancer survivorship : research and practice
Published Date:

Abstract

PURPOSE: Novel approaches are needed to ensure all patients with cancer have access to quality genetic education before genetic testing to enable informed treatment decisions. The purpose of this study was to test the use of an artificial intelligence (AI) intervention for the delivery of genetic education by non-genetic providers to patients with cancer undergoing active treatment.

Authors

  • Kala Visvanathan
    Johns Hopkins School of Medicine and Bloomberg School of Public Health, #E6142 615 N. Wolfe Street, Baltimore, MD, 21231, USA. kvisvan1@jhu.edu.
  • Dana Petry
    Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • Michelle S McCullough
    Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Betty May
    Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Ramkrishnan Tenkasi
    Goodwin College of Business, Benedictine University, Lisle, IL, USA.
  • Nitin Sharma
    Joint Department of Biomedical Engineering, North Carolina State University, Raleigh, NC 27695, USA.
  • Catherine A Klein
    Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • Angelisa Johnson
    Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • Gisselle Killian
    Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Melissa Camp
    Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • Channing J Paller
    Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • Rima Couzi
    Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • Mary Wilkinson
    Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • Lisa Jacobs
    Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • Julie Lange
    Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • Danijela Jelovac
    Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • Michael A Carducci
    Lauren C. Harshman and Christopher J. Sweeney, Dana-Farber Cancer Institute, Harvard Medical School; Yu-Hui Chen, Dana-Farber Cancer Institute, Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group, Boston, MA; Glenn Liu and David Jarrard, University of Wisconsin School of Medicine and Public Health and Carbone Cancer Center, Madison, WI; Michael A. Carducci, Noah Hahn, and Mario Eisenberger, Johns Hopkins University, Baltimore, MD; Robert Dreicer, University of Virginia Cancer Center, Charlottesville, VA; Jorge A. Garcia, Cleveland Clinic Taussig Cancer Institute; Matthew Cooney, University Hospitals Cleveland Medical Center, Seidman Cancer Center, Cleveland, OH; Maha Hussain, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago; Daniel Shevrin, NorthShore University Health System, Evanston, IL; Manish Kohli, Mayo Clinic, Rochester, MN; Elizabeth R. Plimack, Fox Chase Cancer Center, Temple Health, Philadelphia, PA; Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; Joel Picus, Siteman Cancer Center, Washington University School of Medicine, St Louis, MO; and Robert Dipaola, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ.
  • Mehran Habibi
    Johns Hopkins Breast Center, Johns Hopkins Bayview Medical Center, 4940 Eastern Ave, Baltimore, MD, 21224, USA.
  • Gauri Naik
    Optra Health, San Jose, CA, USA.
  • Ashwin Kotwaliwale
    Optra Health, San Jose, CA, USA.